17-beta-estradiol
Weight Gain
University of Colorado, DenverPhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 89/ 100
Competitive context
3 Active assets in the Weight Gain cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Letrozole Nationwide Children's Hospital | Phase 1 | CC |
Capecitabine Oregon Research Institute | N/A | D |
METAMIZOLE Universidad de Sonora | N/A | D |
DEXKETOPROFEN Universidad de Sonora | N/A | D |
NEPENTHE Universidad de Sonora | N/A | D |
Olea europaea oil China Medical University Hospital | N/A | D |
Same molecule, other indications
17-beta-estradiol is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →